GLS Gene — Glutaminase <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">GLS - Glutaminase</th> </tr> <tr> <td class="label">Symbol </td> <td>GLS</td> </tr> <tr> <td class="label">Full Name </td> <td>Glutaminase (Kidney isoform)</td> </tr> <tr> <td class="label">Chromosomal Location </td> <td>2q32.2</td> </tr> <tr> <td class="label">NCBI Gene ID </td> <td>2744</td> </tr> <tr> <td class="label">OMIM ID </td> <td>138280</td> </tr> <tr> <td class="label">Ensembl ID </td> <td>ENSG00000115419</td> </tr> <tr> <td class="label">UniProt ID </td> <td>O94925</td> </tr> <tr> <td class="label">Protein Size </td> <td>598 amino acids</td> </tr> <tr> <td class="label">Molecular Weight </td> <td>~65 kDa</td> </tr> <tr> <td class="label">Drug/Compound</td> <td>Mechanism</td> </tr> <tr> <td class="label">BPTES </td> <td>Allosteric GLS inhibitor</td> </tr> <tr> <td class="label">CB-839 </td> <td>GLS inhibitor</td> </tr> <tr> <td class="label">Compound 968 </td> <td>GAC-selective inhibitor</td> </tr> <tr> <td class="label">DON (6-Diazo-5-oxo-L-norleucine) </td> <td>Irreversible inhibitor</td> </tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/myocardial-infarction" style="color:#ef9a9a">Myocardial Infarction</a></td> <
...
GLS Gene — Glutaminase <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">GLS - Glutaminase</th> </tr> <tr> <td class="label">Symbol </td> <td>GLS</td> </tr> <tr> <td class="label">Full Name </td> <td>Glutaminase (Kidney isoform)</td> </tr> <tr> <td class="label">Chromosomal Location </td> <td>2q32.2</td> </tr> <tr> <td class="label">NCBI Gene ID </td> <td>2744</td> </tr> <tr> <td class="label">OMIM ID </td> <td>138280</td> </tr> <tr> <td class="label">Ensembl ID </td> <td>ENSG00000115419</td> </tr> <tr> <td class="label">UniProt ID </td> <td>O94925</td> </tr> <tr> <td class="label">Protein Size </td> <td>598 amino acids</td> </tr> <tr> <td class="label">Molecular Weight </td> <td>~65 kDa</td> </tr> <tr> <td class="label">Drug/Compound</td> <td>Mechanism</td> </tr> <tr> <td class="label">BPTES </td> <td>Allosteric GLS inhibitor</td> </tr> <tr> <td class="label">CB-839 </td> <td>GLS inhibitor</td> </tr> <tr> <td class="label">Compound 968 </td> <td>GAC-selective inhibitor</td> </tr> <tr> <td class="label">DON (6-Diazo-5-oxo-L-norleucine) </td> <td>Irreversible inhibitor</td> </tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/myocardial-infarction" style="color:#ef9a9a">Myocardial Infarction</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">19 edges</a></td> </tr> </table>
Introduction
Mermaid diagram (expand to render)
The GLS gene (Glutaminase) encodes the enzyme glutaminase, which catalyzes the hydrolysis of glutamine to glutamate. This reaction is crucial for brain metabolism, neurotransmitter synthesis, and cellular energy production. GLS is implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS)[@curthoys1995].
Protein Structure GLS is a homotetrameric enzyme:
N-terminal Domain : Glutamine binding
Catalytic Domain : Hydrolysis reaction center
C-terminal Domain : Regulatory interactions
NAD+ Binding Site : Allosteric regulation
KGA (Kidney-type Glutaminase) : Full-length, widely expressed
GAC (Glutaminase C) : Truncated, highly expressed in brain
LGA : Liver isoform
Normal Function
Glutamine Hydrolysis : GLS converts glutamine to glutamate
Tricarboxylic Acid Cycle : Provides anaplerotic substrate
Glutamate Pool Maintenance : Maintains neurotransmitter glutamate
Neurotransmission
Glutamate Synthesis : Produces neurotransmitter glutamate
GABA Synthesis : Glutamate is precursor for GABA
Ammonia Detoxification : Part of nitrogen metabolism
Anaplerosis : Supplies intermediates for TCA cycle
Astrocyte Function : Critical for astrocyte metabolism
Neuronal Support : Supports neuronal energy needs
Expression Pattern GLS is expressed throughout the brain:
Astrocytes (highest expression)
Neurons (moderate expression)
Oligodendrocytes
Brain regions : Cortex, hippocampus, basal ganglia, cerebellum
Expression is cell-type specific and regulated by metabolic demand.
Disease Associations
Alzheimer's Disease
Glutamate Dysregulation : Altered glutaminase activity in AD brain
Excitotoxicity : Contributes to glutamate-mediated toxicity
Energy Metabolism : Impaired brain glucose metabolism
Therapeutic Target : GLS inhibitors being investigated
Parkinson's Disease
Dopaminergic Neurons : Altered glutamate metabolism in SNc
Excitotoxicity : Contributes to neuron death
Mitochondrial Dysfunction : Links to energy deficits
Amyotrophic Lateral Sclerosis (ALS)
Motor Neuron Vulnerability : Elevated GLS in motor neurons
Excitotoxicity : Excess glutamate contributes to toxicity
Therapeutic Potential : GLS inhibitors show promise
Huntington's Disease
Mutant Huntingtin : Alters glutaminase regulation
Metabolic Dysfunction : Contributes to energy deficits
Therapeutic Targeting
Regulation GLS is regulated by:
Allosteric Activation : ADP, phosphate activate
Allosteric Inhibition : Glutamate,product inhibition
Transcriptional Regulation : p53, c-Myc
Post-translational Modification : Phosphorylation, acetylation
GLS connects multiple metabolic pathways:
Glutamine → Glutamate → TCA Cycle
Glutamate → GABA (GABA shunt)
Glutamine → Glutathione synthesis
See Also
[Glutamate Signaling Pathway](/mechanisms/glutamate-signaling-pathway)
[Glutamate Receptor Signaling](/mechanisms/glutamate-receptor-signaling)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Energy Metabolism](/mechanisms/energy-metabolism)
[Excitotoxicity](/mechanisms/excitotoxicity)
External Links
[NCBI Gene: GLS](https://www.ncbi.nlm.nih.gov/gene/2744)
[UniProt: O94925](https://www.uniprot.org/uniprot/O94925)
[OMIM: 138280](https://www.omim.org/entry/138280)
[GeneCards: GLS](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GLS)
References
[Curthoys NP, et al., Kidney-type glutaminase (1995) (1995)](https://pubmed.ncbi.nlm.nih.gov/7647979/)
[Yang C, et al., Glutaminase in neurodegenerative disease (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21855433/)
[Thomas AG, et al., GLS inhibitors for therapeutic use (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25010966/)
[Sattler R, et al., Glutaminase in ALS (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29341231/)
Pathway Diagram The following diagram shows the key molecular relationships involving GLS - Glutaminase discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description